Skip to content
Search

Latest Stories

RPS urges government to ban ‘diet drug’ DNP for human consumption

The Royal Pharmaceutical Society (RPS) is calling on the Home Office to ban the industrial chemical 2,4-Dinitrophenol (DNP), stating it to be unfit for human consumption.

According to National Poison Information Service report 2020/21, DNP has led to 32 deaths since 2007 among those taking it after being supplied online as a ‘diet drug’.


The main use of DNP is in the manufacture of explosives and pesticides. It can also reduce body fat by speeding up the metabolism and is sold by unscrupulous dealers to vulnerable individuals wanting to lose weight. It is highly dangerous to health and should never be used for weight loss.

Responding to the Home Office consultation on changes to the Poisons Act 1972, RPS urged the government to immediately ban DNP to reduce the danger to the public, to prosecute those seeking to profit from DNP and to encourage other countries to do the same.

Between 2007 and 2020, the UK National Poisons Information Service recorded 138 cases of poisoning due to DNP. Of those who presented at hospital between 2007 and 2019 with a history of having taken DNP, 18 per cent died.

RPS President Professor Claire Anderson said: “We welcome the fact that DNP could be added to the Poisons List, which we have been calling for since 2019. But we believe that DNP should be completely banned and not supplied under any circumstances. There is no legitimate human or animal use for DNP and over the last 15 years 32 people have died from taking it.

“We are concerned that DNP is still in circulation and often targeted to image conscious young people who may want to try quick fixes to improve their body image. Don’t ever believe what you see online about DNP – if you want to lose weight, talk to a health professional instead. You’re dicing with death if you buy DNP online.

“If the Home Office will not consider a ban, then as well as adding DNP to the Poisons List to control its supply, legislation should be passed that prohibits the compounding of DNP. This would make it illegal to put DNP into sachets or capsules for human, animal or agricultural use.”

More For You

Vaccine-preventable infections costing UK billions

Effective interventions are needed to prevent hospitalisations

Vaccine-preventable infections costing UK billions

Effective interventions are having a positive impact but more needs to be done to combat vaccine-preventable infections after data revealed today showed that it accounted for 20 per cent of hospital bed usage in the UK between 2023 to 2024 at a cost of almost £6 billion.

The return of social mixing, international travel and migration following the COVID-19 pandemic have contributed to the rise in both endemic disease and vaccine-preventable infections, according to the UK Health Security Agency's (UKHSA).

Keep ReadingShow less
Economic analysis of pharmacy finances will be published ‘imminently’ - Stephen Kinnock

Stephen Kinnock also confirms that the outcome of the negotiations with CPE will be announced "very soon."

parliamentlive.tv

NPA collective action “premature, unnecessary and detrimental to patients” - Stephen Kinnock

Health Minister Stephen Kinnock has announced that the government will be releasing the independent economic analysis of pharmacy finances “imminently.”

Responding to a question from shadow health minister Dr. Luke Evans in Parliament today (25), Kinnock criticised the National Pharmacy Association’s (NPA) collective action as “premature, unnecessary, and detrimental to community pharmacy patients.”

Keep ReadingShow less
NPA members are expected reduce opening hours and services from next week

NPA members are expected reduce opening hours and services from next week

Pic credit: iStock

NPA will become more “militant” as wait for pharmacy contract goes on

The government has been warned by the National Pharmacy Association (NPA) that community pharmacy will not back down from collective action and reducing opening hours from April 1st.

NPA board member, Ashley Cohen, told LBC today that the sector was in a "desperate situation" and that the representative body will do “whatever we can to protect our sector”.

Keep ReadingShow less
Community pharmacy needs investment and support to deliver neighbourhood health, says CCA chief

Community pharmacies see patients more than anyone else in the primary care system.

Getty Images

Community pharmacy key to neighbourhood health, but investment needed, says CCA chief

Community pharmacies can play a vital role in delivering a ‘neighbourhood health service’, provided they receive the necessary investment and support, according to Malcolm Harrison, chief executive of the Company Chemists’ Association (CCA).

Harrison's comments come in response to a new report from think tank Reform, titled Designing a Neighbourhood Health Service, which outlines key principles for achieving the government's vision of a more community-focused healthcare system.

Keep ReadingShow less
Mike Hewitson, superintendent pharmacist & managing director of Beaminster Pharmacy

Mike Hewitson elected as NPA board member for England

Mike Hewitson elected as NPA board member for England: New term begins April

Mike Hewitson, superintendent pharmacist & managing director ofBeaminster Pharmacy, has been elected as the next National Pharmacy Association (NPA) board member for England.

Since 2023, Hewitson has served as chair of Community Pharmacy Dorset. He is also a member of Somerset Council and a Non-Executive Director at HubRx.

Keep ReadingShow less